INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.160
-0.070 (-3.14%)
At close: Aug 20, 2026, 4:00 PM EDT
2.179
+0.019 (0.89%)
After-hours: Aug 20, 2026, 5:39 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $59.95 million as of August 20, 2026. Its market cap has decreased by -6.04% in one year.
Market Cap
59.95M
Enterprise Value
42.94M
1-Year Change
-6.04%
Ranking
Category
Stock Price
$2.16
ChartMarket Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $59.95M, a decrease of -22.97%. That is a compound annual growth rate of -3.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 59.95M | 44.55% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 68.13M |
| MediciNova | 67.93M |
| Rein Therapeutics | 67.75M |
| Boundless Bio | 65.06M |
| OS Therapies | 65.03M |
| ImageneBio | 64.59M |
| Xilio Therapeutics | 61.92M |
| Heron Therapeutics | 59.78M |